https://www.selleckchem.com/pr....oducts/adenosine-cyc
The anticoagulant therapy with acenocoumarol is generally associated with a high risk of bleeding and thromboembolic events. We applied eight already existing acenocoumarol dosing algorithms to Bulgarian patients with low acenocoumarol dose requirements and investigated which of these algorithms would predict most precisely the dose anticoagulant. Two patients with Bulgarian origin were referred to the outpatient clinical laboratory of "St. Ekaterina" University Hospital for Cardiovascular Surgery and Cardiology, Sofia,
Like
Comment
Share
